{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:45:39Z","timestamp":1794336339643,"version":"4.9.0"},"reference-count":123,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation Research"],"published-print":{"date-parts":[[2021,5,14]]},"abstract":"<jats:p>Often considered a rare disease, cardiac amyloidosis is increasingly recognized by practicing clinicians. The increased rate of diagnosis is in part due the aging of the population and increasing incidence and prevalence of cardiac amyloidosis with advancing age, as well as the advent of noninvasive methods using nuclear scintigraphy to diagnose transthyretin cardiac amyloidosis due to either variant or wild type transthyretin without a biopsy. Perhaps the most important driver of the increased awareness is the elucidation of the biologic mechanisms underlying the pathogenesis of cardiac amyloidosis which have led to the development of several effective therapies with differing mechanisms of actions. In this review, the mechanisms underlying the pathogenesis of cardiac amyloidosis due to light chain (AL) or transthyretin (ATTR) amyloidosis are delineated as well as the rapidly evolving therapeutic landscape that has emerged from a better pathophysiologic understanding of disease development.<\/jats:p>","DOI":"10.1161\/circresaha.121.318187","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:00:31Z","timestamp":1620928831000},"page":"1554-1575","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":212,"title":["Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis"],"prefix":"10.1161","volume":"128","author":[{"given":"Jan M.","family":"Griffin","sequence":"first","affiliation":[{"name":"Division of Cardiology, Cardiovascular Research Laboratory for the Elderly, Columbia University Irving Medical Center, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Rosenblum","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Research Laboratory for the Elderly, Columbia University Irving Medical Center, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1867-0526","authenticated-orcid":true,"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Research Laboratory for the Elderly, Columbia University Irving Medical Center, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.003"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.10.001"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024438"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20140155"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi301313b"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400062101"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15424-3"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02261"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0101-y"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5446.1888"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023144"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.022"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi001782b"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-0109-0"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.01.018"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.9b00311"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsbi.2000.4248"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-355784"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.1"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.07.016"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2019.05.002"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2013.11929013"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.75.101304.123901"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.12.5602"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.10.4299"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1039\/c4cp05563b"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.659912"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature20416"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000706"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2411"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1759"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.12793"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.910455"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006242"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000126569.75419.74"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912263107"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5724"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4385"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079589"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1817567116"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504942"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.4741.4741"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2019.1584892"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1805131115"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.005257"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3779"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716793"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.004"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0326-6"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716153"},{"key":"e_1_3_3_52_2","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.neurol.2019.01.339","article-title":"Phase 1 study of ALN-TTRsc02, a subcutaneously administered investigational RNAi therapeutic for the treatment of transthyretin-mediated amyloidosis.","volume":"175","author":"Adams D","year":"2019","unstructured":"Adams, D, Verena, K. Phase 1 study of ALN-TTRsc02, a subcutaneously administered investigational RNAi therapeutic for the treatment of transthyretin-mediated amyloidosis. Revue Neurologique. 2019;175:S129.","journal-title":"Revue Neurologique"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13154"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129269"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.02.014"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1808783"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2012.00303.x"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2019.11.024"},{"key":"e_1_3_3_59_2","first-page":"27","article-title":"Compound heterozygotes of transthyretin Met30 and transthyretin Met119 are protected from the devastating effects of familial amyloid polyneuropathy.","volume":"6","author":"Coehlo T","year":"1996","unstructured":"Coehlo, T, Chorao, R, Sousa, A, Alves, I, Torres, M, Saraiva, M. Compound heterozygotes of transthyretin Met30 and transthyretin Met119 are protected from the devastating effects of familial amyloid polyneuropathy. Neuromuscul Disord. 1996;6:27.","journal-title":"Neuromuscul Disord"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182661eb1"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.789"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00817"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201608516"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300761110"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.012"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10787"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.5233"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.045093"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25149"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v6.i2.380"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000834"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0258-y"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.7614"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.7.7.945"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12762"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.095463"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253237"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960x(92)90028-o"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01721"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3465-8"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1924"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2005.10.001"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-396903"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294405"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-407791"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-756528"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.2174\/156800911794519716"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.100663"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.4947"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-620302"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.029"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.227"},{"key":"e_1_3_3_94_2","volume-title":"In: Exploring New Findings on Amyloidosis","author":"Driscoll J","year":"2016","unstructured":"Driscoll, J, Girnius, S. Proteasome inhibitors to treat AL amyloidosis. Fernandez-Escamilla, A.-M. ed. In: Exploring New Findings on Amyloidosis: IntechOpen; 2016."},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16122"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-771220"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.8546"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003032"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12389"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506348"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-763599"},{"key":"e_1_3_3_102_2","volume-title":"Paper presented at: The XVIth International Symposium on Amyloidosis","author":"Hossein Taghizadeh M","unstructured":"Hossein Taghizadeh, M, Reiter, T, Duca, F, Binder, C, Kornauth, M-T, Christoph, HA. Daratumumab \u2013 a safe first-line treatment of cardiac AL amyloidosis in heavily compromised patients. Paper presented at: The XVIth International Symposium on Amyloidosis; March 26\u201329, 2018; Kumamoto, Japan."},{"key":"e_1_3_3_103_2","volume-title":"Paper presented at: EHA25 Virtual Congress","author":"Kastritis E","unstructured":"Kastritis, E, Palladini, G, Minnema, M, Wechalekar, A, Jaccard, A, Lee, H, Sanchorawala, V, Gibbs, S, Mollee, P, Venner, CP, et al. Subcutaneous daratumumab + cyclophosphamide, bortezomib, and dexamethasone (CyBorD) in patients with newly diagnosed light chain amyloidosis. Paper presented at: EHA25 Virtual Congress, June 11-21, 2020"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.229"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1597"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-107292"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1493-8"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.08.021"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2018.1548931"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.216"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.108.788687"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100361"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2019.01.006"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-273797"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09494"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.6530"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-132062"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.12.013"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.11.015"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14028"},{"key":"e_1_3_3_121_2","unstructured":"Thoracic Organ Transplant Committee. Review Board Guidance for Hypertrophic\/Restrictive (HCM\/RCM) Cardiomyopathy Exception Requests. 2018. Accessed May 26 2020. https:\/\/optn.transplant.hrsa.gov\/media\/2637\/thoracic_guidance_review_board_hcm_rcm_201806.pdf"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14109"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2788"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-413161"}],"container-title":["Circulation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCRESAHA.121.318187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:52:44Z","timestamp":1715575964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCRESAHA.121.318187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":123,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,5,14]]}},"alternative-id":["10.1161\/CIRCRESAHA.121.318187"],"URL":"https:\/\/doi.org\/10.1161\/circresaha.121.318187","relation":{},"ISSN":["0009-7330","1524-4571"],"issn-type":[{"value":"0009-7330","type":"print"},{"value":"1524-4571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"assertion":[{"value":"2021-05-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}